NCT03580239 2018-07-09Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway DeficiencyTianjin Medical University Second HospitalPhase 3 Unknown120 enrolled